Company intelligence
Rare Medical Network
Rare disease education and promotion. Social reach.
About Rare Medical Network
The Rare Medical Network (RMN), a group of 17 specialty-specific interactive educational websites and associated e-newsletters, is designed to more effectively educate healthcare professionals about rare diseases, rare tumor types, and other highly-specific disorders. Because there are more than 7,500 rare diseases, creating specialty-specific content is important to making educational information relevant to medical professionals. WHY HCPs COME TO US FOR EDUCATION Each of the RMN sites is designed using adult learning techniques to facilitate rapid uptake of information. Quick facts, (5 Key Facts), peer quizzes, (What's Your RareiQ?), and video-based diagnostic challenges, (Rare Mysteries) are just a few of the many features found on our sites. Each site also provides access to a unique database of more than 6,000 rare disease profiles, with infographics designed to accelerate knowledge transfer. To accelerate engagement with RMN specialty websites, RMN has partnered with Equals 5, a biopharma ad-tech company that uses proprietary algorithms to provide NPI-level targeting on social media with physician-level data (PLD) reporting on engagement. With Equals 5, RMN can reach 1.5M HCPs across nine social media networks. RMN also reaches HCPs through its proprietary email database of over 500,000 healthcare professionals. HOW WE HELP BIOPHARMA Our biopharma clients need to educate HCPs both about the diseases their products address, and the products themselves, but often struggle to effectively reach HCPs and achieve tangible real-world results (ie., increasing disease and treatment awareness, driving patient identification, etc.). The Rare Medical Network is an ideal content marketing platform that provides a targeted and credible channel to educate HCPs.
Verified activity
Signals from Rare Medical Network
4 published signals
Research & Knowledge
Rare Medical Network published a controlled primary research study showing that HCPs who engaged with APDS content on the Rare Immunology News website reported a 74% higher knowledge of APDS compared to physicians who did not participate in the program.
Reported by Jack Davis
Research & Knowledge
Rare Medical Network reported that after 12 months, 76 genetic tests ordered were made for a condition where the disease was unknown and the test reflex didn't exist.
Reported by Jack Davis
Research & Knowledge
Rare Medical Network reported that the APDS program reached 39,650 physicians across four specialties and resulted in 5 confirmed new patient identifications.
Reported by Jack Davis
Research & Knowledge
Rare Medical Network published Rare Barometer 2024 data from 6,500+ patients across 41 countries showing an average diagnostic odyssey of 4.7 years.
Reported by Jack Davis